COX-2 in liver,from regeneration to hepatocarcinogenesis:What we have learned from animal models?

被引:12
|
作者
Paloma Martín-Sanz [1 ,2 ]
Rafael Mayoral [1 ,2 ]
Marta Casado [1 ,3 ]
Lisardo Boscá [1 ,2 ]
机构
[1] Biomedical Network Center for the Study of Hepatic and Digestive Diseases(CIBERehd)
[2] Department of Metabolism and Cell Signaling,Institute of Biomedical Research "Alberto Sols"(CSIC-UAM)
[3] Department of Pathology and Molecular and Cellular Therapy,Institute of Biomedicine of Valencia(IBV-CSIC)
关键词
Cyclooxygenase; 2; Prostaglandins; Liver diseases; Apoptosis; Inflammation; Animal models;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
The use of animals lacking genes or expressing genes under the control of cell-specific promoters has signifi cantly increased our knowledge of the genetic and molecular basis of physiopathology,allowing testing of functional hypotheses and validation of biochemical and pharmacologic approaches in order to understand cell function.However,with unexpected frequency,gene knockout animals and,more commonly,animal models of transgenesis give experimental support to even opposite conclusions on gene function.Here we summarize what we learned on the role of cyclooxygenase 2(COX-2) in liver and revise the results obtained in 3 independent models of mice expressing a COX-2 transgene specifi cally in the hepatocyte.Upon challenge with pro-inflammatory stimuli,the animals behave very differently,some transgenic models having a protective effect but others enhancing the injury.In addition,one transgene exerts differential effects on normal liver physiology depending on the transgenic animal model used.
引用
收藏
页码:1430 / 1435
页数:6
相关论文
共 50 条
  • [21] Vascular Calcification in Chronic Renal Failure What Have We Learned From Animal Studies?
    Neven, Ellen
    D'Haese, Patrick C.
    CIRCULATION RESEARCH, 2011, 108 (02) : 249 - 264
  • [22] Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
    Delire, Benedicte
    Starkel, Peter
    Leclercq, Isabelle
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2015, 3 (01) : 53 - 66
  • [23] The Splenic Response to Ischemic Stroke: What Have We Learned from Rodent Models?
    Leonardo, Christopher C.
    Pennypacker, Keith R.
    TRANSLATIONAL STROKE RESEARCH, 2011, 2 (03) : 328 - 338
  • [24] What we have learned from inherited platelet disorders
    Israels, Sara J.
    Rand, Margaret L.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (01) : S2 - S7
  • [25] What can we learn from animal models of alopecia areata?
    McElwee, KJ
    Yu, M
    Park, SW
    Ross, EK
    Finner, A
    Shapiro, J
    DERMATOLOGY, 2005, 211 (01) : 47 - 53
  • [26] Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models
    Lassmann, Hans
    EXPERIMENTAL NEUROLOGY, 2010, 225 (01) : 2 - 8
  • [27] Alveolus formation: what have we learned from genetic studies?
    Yan, C
    Du, H
    JOURNAL OF APPLIED PHYSIOLOGY, 2004, 97 (04) : 1543 - 1548
  • [28] Cardiovascular Dysfunction Following Burn Injury: What We Have Learned from Rat and Mouse Models
    Guillory, Ashley N.
    Clayton, Robert P.
    Herndon, David N.
    Finnerty, Celeste C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (01)
  • [29] Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics
    Laura Padrón-Barthe
    Fernando Domínguez
    Pablo Garcia-Pavia
    Enrique Lara-Pezzi
    Basic Research in Cardiology, 2017, 112
  • [30] Animal models of arrhythmogenic right ventricular cardiomyopathy: what have we learned and where do we go? Insight for therapeutics
    Padron-Barthe, Laura
    Dominguez, Fernando
    Garcia-Pavia, Pablo
    Lara-Pezzi, Enrique
    BASIC RESEARCH IN CARDIOLOGY, 2017, 112 (05)